BioLineRx Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IL0011015182
ILS
0.02
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Sep'23
Net Sales
0.92
43.50
18.35
20.10
25.12
18.35
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
0.92
43.50
18.35
20.10
25.12
18.35
0.00
Raw Material Cost
0.72
22.96
4.59
4.26
5.33
14.11
0.83
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.52
16.59
6.03
7.77
3.40
0.00
3.13
Selling and Distribution Expenses
2.98
26.28
24.25
29.06
28.32
37.72
35.22
Other Expenses
0.43
-0.97
0.35
0.05
0.57
1.19
0.71
Total Expenditure (Excl Depreciation)
9.56
56.14
38.35
41.61
42.79
63.69
46.25
Operating Profit (PBDIT) excl Other Income
-8.6
-12.6
-20
-21.5
-17.7
-45.300000000000004
-46.3
Other Income
28.68
21.17
4.42
31.08
18.52
17.90
-10.59
Operating Profit (PBDIT)
20.64
15.49
-12.46
12.28
3.22
-24.75
-56.01
Interest
1.52
16.59
6.03
7.77
3.40
0.00
3.13
Exceptional Items
0.00
-3.74
0.00
0.00
0.00
-25.62
0.00
Gross Profit (PBDT)
0.20
20.54
13.77
15.84
19.79
4.23
-0.83
Depreciation
0.60
6.96
3.12
2.71
2.37
2.70
0.83
Profit Before Tax
18.52
-11.80
-21.62
1.80
-2.55
-53.07
-59.97
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
18.52
-11.80
-21.62
1.80
-2.55
-53.07
-59.97
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
18.52
-11.80
-21.62
1.80
-2.55
-53.07
-59.97
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
18.52
-11.80
-21.62
1.80
-2.55
-53.07
-59.97
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
77.75
49.05
31.64
52.67
47.85
47.61
50.00
Earnings per share (EPS)
0.01
-0.01
-0.02
0.0
-0.0
-0.05
-0.06
Diluted Earnings per share
0.01
-0.01
-0.02
0.0
-0.0
-0.05
-0.06
Operating Profit Margin (Excl OI)
-937.65%
-29.07%
-108.98%
-107.05%
-70.34%
-247.15%
0.0%
Gross Profit Margin
2075.29%
-11.12%
-100.79%
22.46%
-0.73%
-274.54%
0.0%
PAT Margin
2010.59%
-27.13%
-117.78%
8.97%
-10.15%
-289.25%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2025 is -96.41% vs 0.00% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2025 is 811.54% vs 93.95% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2025 is 47.71% vs 49.67% in Mar 2024

stock-summary

Interest

YoY Growth in quarter ended Mar 2025 is -55.88% vs 3.03% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024

Compare Quarterly Results Of BioLineRx Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(ILS)
Change(%)
Net Sales
0.92
0
0.92
Other Operating Income
0.00
0.00
0.00
Total Operating income
0.92
0
0.92
Raw Material Cost
0.72
0
0.72
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
1.52
0
1.52
Selling and Distribution Expenses
2.98
0
2.98
Other Expenses
0.43
0.00
0.43
Total Expenditure (Excl Depreciation)
9.56
0
9.56
Operating Profit (PBDIT) excl Other Income
-8.64
0.00
-8.64
Other Income
28.68
0
28.68
Operating Profit (PBDIT)
20.64
0
20.64
Interest
1.52
0
1.52
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
0.20
0
0.20
Depreciation
0.60
0
0.60
Profit Before Tax
18.52
0
18.52
Tax
0.00
0
0.00
Provisions and contingencies
0
0
0.00
Profit After Tax
18.52
0
18.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
18.52
0
18.52
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
18.52
0
18.52
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
77.75
0
77.75
Earnings per share (EPS)
0.01
0
0.01
Diluted Earnings per share
0.01
0
0.01
Operating Profit Margin (Excl OI)
-937.65%
0%
0.00
-937.65%
Gross Profit Margin
2,075.29%
0%
0.00
2,075.29%
PAT Margin
2,010.59%
0%
0.00
2,010.59%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 0.09 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -97.93% vs 136.41% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -96.41% vs 0.00% in Mar 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1.85 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is 256.78% vs 45.37% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 811.54% vs 93.95% in Mar 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -0.80 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -40.35% vs 66.27% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is 47.71% vs 49.67% in Mar 2024

Quarterly - Interest
Interest 0.15 Million
in Mar 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2025 is -90.96% vs 176.67% in Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 is -55.88% vs 3.03% in Mar 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -937.65%
in Mar 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2025 has fallen from Dec 2024

stock-summary

YoY Growth in quarter ended Mar 2025 has fallen from Mar 2024